Comparative efficacy of indacaterol in chronic obstructive pulmonary disease

Long-acting bronchodilators have been shown to improve multiple clinical outcomes in chronic obstructive pulmonary disease (COPD) including lung function, symptoms, dyspnea, quality of life, and exacerbations. Indacaterol is a novel, inhaled, long-acting β2-agonist providing 24-hour bronchodilation...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Marcos, Chapman, Kenneth R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299544/
https://www.ncbi.nlm.nih.gov/pubmed/22419862
http://dx.doi.org/10.2147/COPD.S19805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299544/
https://www.ncbi.nlm.nih.gov/pubmed/22419862
http://dx.doi.org/10.2147/COPD.S19805

Ejemplares similares